Vincristine chemotherapy trials and pharmacokinetics in tasmanian devils with tasmanian devil facial tumor disease.
Tasmanian Devil Facial Tumor Disease (DFTD) is a transmissible cancer threatening to cause the extinction of Tasmanian Devils in the wild. The aim of this study was to determine the susceptibility of the DFTD to vincristine. Escalating dosage rates of vincristine (0.05 to 0.136 mg/kg) were given to...
Guardado en:
Autores principales: | David N Phalen, Angela Frimberger, Stephen Pyecroft, Sarah Peck, Colette Harmsen, Suzanneth Lola, Beatriz de Mello Mattos, Kong M Li, Andrew J McLachlan, Antony Moore |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c0961d8036c2492d8e701f6ad689db53 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Untangling the model muddle: Empirical tumour growth in Tasmanian devil facial tumour disease
por: Rodrigo K. Hamede, et al.
Publicado: (2017) -
Rapid evolutionary response to a transmissible cancer in Tasmanian devils
por: Brendan Epstein, et al.
Publicado: (2016) -
Whisker growth in Tasmanian devils (Sarcophilus harrisii) and applications for stable isotope studies
por: Marie R. G. Attard, et al.
Publicado: (2021) -
No evidence of inbreeding depression in a Tasmanian devil insurance population despite significant variation in inbreeding
por: Rebecca Gooley, et al.
Publicado: (2017) -
Increasing generations in captivity is associated with increased vulnerability of Tasmanian devils to vehicle strike following release to the wild
por: Catherine E. Grueber, et al.
Publicado: (2017)